GnRH Antagonist Protocol With Cessation of Cetrorelix on Trigger Day Improves Embryological Outcomes for Patients With Sufficient Ovarian Reserve

OBJECTIVE: To evaluate the efficiency and validity of cessation of cetrorelix on trigger day during gonadotropin releasing hormone antagonist (GnRH-ant)-controlled ovarian stimulation of in vitro fertilization (IVF) cycles. METHODS: In this retrospective study, a total of 1271 patients undergoing in...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Huihui, Zhao, Shen, Gao, Xinxing, Wu, Xian, Xia, Lan, Zhang, Dan, Li, Jian, Zhang, Aijun, Xu, Bufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551826/
https://www.ncbi.nlm.nih.gov/pubmed/34721305
http://dx.doi.org/10.3389/fendo.2021.758896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551826/
https://www.ncbi.nlm.nih.gov/pubmed/34721305
http://dx.doi.org/10.3389/fendo.2021.758896

Ejemplares similares